Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report) shares were down 13.7% during trading on Thursday . The stock traded as low as $0.90 and last traded at $1.01. Approximately 128,134 shares were traded during mid-day trading, a decline of 33% from the average daily volume of 191,072 shares. The stock had previously closed at $1.17.
Seelos Therapeutics Price Performance
The company has a 50-day moving average price of $1.00 and a 200 day moving average price of $1.37.
Seelos Therapeutics (NASDAQ:SEEL – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported $0.12 EPS for the quarter. The company had revenue of $0.38 million during the quarter.
Institutional Inflows and Outflows
Seelos Therapeutics Company Profile
Seelos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD).
Further Reading
- Five stocks we like better than Seelos Therapeutics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Upcoming IPO Stock Lockup Period, Explained
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Seelos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seelos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.